首页> 外文期刊>Canadian Urological Association Journal >Long-term outcomes after radical or partial nephrectomy for T1a renal cell carcinoma: A population-based study
【24h】

Long-term outcomes after radical or partial nephrectomy for T1a renal cell carcinoma: A population-based study

机译:用于T1A肾细胞癌的自由基或部分肾切除术后的长期结果:基于人群的研究

获取原文
           

摘要

Introduction: The benefit of partial nephrectomy (PN) compared to radical nephrectomy (RN) for T1a renal cell carcinoma (RCC) remains uncertain, with observational studies conflicting with level 1 evidence. Therefore, the purpose of this population-based study was to compare long-term outcomes in patients undergoing PN or RN for T1a RCC. Methods: We studied 5670 patients in Ontario, Canada undergoing PN or RN for T1a RCC. The primary outcome was overall survival (OS). Secondary outcomes were cancer-specific survival (CSS), chronic kidney disease (CKD), end-stage renal disease (ESRD), and myocardial infarction (MI). We used multivariable Cox proportional hazard models to evaluate the association between PN or RN and these outcomes. A sensitivity analysis was performed in patients with a preoperative serum creatinine available. Results: Median followup was 77 months. Compared to RN, PN was associated with significantly improved OS (hazard ratio [HR] 0.73; 95% confidence interval [CI] 0.63–0.84), reduced risk of CKD (HR 0.18; 95% CI 0.12–0.27) and improved CSS (HR 0.45; 95% CI 0.30–0.65). The risk of myocardial infarction was not significantly different between groups (HR 0.91; 95% CI 0.62–1.34). Few patients (n=15) required renal replacement therapy. In the sensitivity analysis, the association between type of surgery and OS and CKD persisted, while the association with CSS did not. Conclusions: Our study found that in patients undergoing surgery for T1a RCC, PN was associated with improved OS and reduced risk of CKD compared to RN. However, few patients in either group developed ESRD requiring renal replacement therapy.
机译:引言:部分肾切除术(PN)与用于T1A肾细胞癌(RC)的根治性肾切除术(RN)仍然不确定,观察研究与1级证据相互矛盾。因此,基于群体的研究的目的是比较经历PN或RN的患者的长期结果。方法:我们研究了5670名患者,在加拿大安大略省患者进行PN或RN进行T1A RCC。主要结果是总体存活(OS)。二次结果是癌症特异性存活(CSS),慢性肾病(CKD),末期肾病(ESRD)和心肌梗塞(MI)。我们使用多变量的Cox比例危险模型来评估PN或RN之间的关联以及这些结果。患有术前血清肌酐的患者进行敏感性分析。结果:中位关注为77个月。与RN相比,PN与显着改善的OS(危害比[HR] 0.73; 95%置信区间[CI] 0.63-0.84)相关,CKD的风险降低(HR 0.18; 95%CI 0.12-0.27)和改善的CSS( HR 0.45; 95%CI 0.30-0.65)。基团之间的心肌梗死风险没有显着差异(HR 0.91; 95%CI 0.62-1.34)。少数患者(n = 15)所需的肾置换疗法。在敏感性分析中,手术类型与OS和CKD之间的关联持续存在,而与CSS的关联没有。结论:我们的研究发现,在接受T1A RCC手术的患者中,PN与改善的操作系统相关,并且与RN相比降低了CKD的风险。然而,在任一组中少数患者开发ESRD需要肾置换疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号